| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8711506 | Annales de Dermatologie et de Vénéréologie | 2017 | 9 Pages |
Abstract
The treatment of atopic dermatitis in adults is based on the use of topical steroids and emollients. When AD is resistant to a well-conducted topical treatment, phototherapy or systemic treatments can be used: ciclosporin, methotrexate, azathioprine or mycophenolate mofetil. The therapeutic landscape of adult AD is about to change and even be revolutionized by the imminent arrival of new treatments: topical phosphodiesterase 4 inhibitors, topical or systemic JAK inhibitors, anti-IL-4 and/or antiIL-13 biotherapies (dupilumab, tralokinumab, lebrikizumab), anti-IL-31 (nemolizumab), anti-TSLP.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
J.-P. Lacour,